|
|
Volumn 3, Issue SUPPL. 2, 2008, Pages 1-2
|
|
The role of uPA and uPA inhibitors in breast cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA 2 ANTIPLASMIN;
BIOLOGICAL MARKER;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
PLASMIN;
PLASMINOGEN;
PLASMINOGEN ACTIVATOR INHIBITOR;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
UNCLASSIFIED DRUG;
UROKINASE;
WX 671;
APOPTOSIS;
BREAST CANCER;
CLINICAL TRIAL;
CONFERENCE PAPER;
HUMAN;
METASTASIS;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN BINDING;
PROTEIN DEGRADATION;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
RECEPTOR BINDING;
|
|
EID: 56249114472
PISSN: 16613791
EISSN: 16613805
Source Type: Journal
DOI: 10.1159/000151735 Document Type: Conference Paper |
|
Times cited : (8)
|
|
References (0)
|
